Aethlon Medical (AEMD) shares soared 346% premarket on Thursday as it agreed on an all-stock merger with North Immunology. The transaction, approved by both boards, is expected to close in the first ...
North Immunology is going public in a reverse merger with Aethlon Medical. With eczema as the lead indication, the inflammation and immunology biotech aims to show its bispecific antibody offers ...
Armed with $180 million and a dual-acting antibody for eczema, the startup is capitalizing on a change in sentiment that’s ...
Aethlon Medical (NASDAQ:AEMD) shares surged more than 400% in pre-market trading on Thursday after the company announced a ...
Aethlon Medical (AEMD) stock jumped 471% after revealing merger with North Immunology, backed by $180M funding for atopic dermatitis drug development.
Aethlon Medical, Inc. ( AEMD) shares are surging more than 470% after the company announced a definitive all-stock merger agreement with North Immunology, along with an oversubscribed $180 million ...
Aethlon Medical (AEMD) stock surged 471% after announcing an all-stock merger with North Immunology, backed by a $180M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results